Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosis
- 1 October 1980
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 17 (2) , 280-286
- https://doi.org/10.1016/0090-1229(80)90097-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 casesClinical Immunology and Immunopathology, 1978
- Monoclonal gammopathy of undetermined significanceThe American Journal of Medicine, 1978
- Clinical Features of Patients with a Serum M ComponentActa Medica Scandinavica, 1978
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCEBritish Journal of Haematology, 1973
- Serum Viscosity and Hyperviscosity Syndrome in IgG Multiple MyelomaAnnals of Internal Medicine, 1972
- Primary Amyloidosis with Plasmacytic Dyscrasia and a Tetramer of Bence Jones Type Lambda Globulin in the Serum and UrineBlood, 1971
- Plasmacytic myelomaThe American Journal of Medicine, 1967
- MyelomatosisActa Medica Scandinavica, 1964
- Plasma-Cell MyelomaNew England Journal of Medicine, 1959